| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 144 |
| 16 Nov 2026 | 144 |
| 16 Nov 2026 |
Form 4: Kramer Kelly A., Director
Received 10,376 shares by exercise or conversion ($694K) · Sold 10,376 shares ($1.76M) |
| 12 Nov 2026 | 144 |
| 09 Nov 2026 |
Form 4: Cain Wettan Keeley M, EVP Gen Counsel, Legal & Comp
Sold 3,399 shares ($558K) |
| 06 Nov 2026 | SCHEDULE 13G |
| 06 Nov 2026 |
Form 4: O'Day Daniel Patrick, Director
Received 102,619 shares by exercise or conversion ($7.42M) · Sold 102,619 shares ($18M) · Received 9,810 shares by exercise or conversion ($710K) · 1 more |
| 06 Nov 2026 | 144 |
| 06 Nov 2026 | 13F-HR |
| 04 Nov 2026 | 144 |
| 02 Nov 2026 |
Form 4: O'Day Daniel Patrick, Director
Received 15,881 shares by exercise or conversion ($1.15M) · Sold 15,881 shares ($2.78M) · Sold 15,000 shares ($2.55M) |
| 30 Oct 2026 | 144 |
| 30 Oct 2026 | FORM 10-Q |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Product Sales Excluding Veklury Increased 16% Year-Over-Year to $8.2 Billion |
| 16 Oct 2026 |
Form 4: Dickinson Andrew D, Chief Financial Officer
Sold 3,000 shares ($469K) |
| 16 Oct 2026 |
Form 4: Mercier Johanna, Chief Comm & Corp Aff Officer
Sold 3,000 shares ($469K) |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 | 144 |
| 02 Oct 2026 |
Form 4: O'Day Daniel Patrick, Director
Sold 15,000 shares ($2.22M) |
| 23 Sep 2026 |
Form 4: Burkhart Erin, SVP, Controllership
Received 2,223 shares by exercise or conversion · Gave up 768 shares to cover exercise price or tax ($117K) |
Loading...